Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Autor: Burnett, Alan K, Russell, Nigel H, Hills, Robert K, Bowen, David, Kell, Jonathan, Knapper, Steve, Morgan, Yvonne G, Lok, Jennie, Grech, Angela, Jones, Gail, Khwaja, Asim, Friis, Lone, McMullin, Mary Frances, Hunter, Ann, Clark, Richard E, Grimwade, David
Zdroj: In The Lancet Oncology October 2015 16(13):1295-1305
Databáze: ScienceDirect